Louis Frederic Diehl, MD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
Phone (919) 668-1000
Email address louis.diehl@duke.edu

Research interests include Hodgkin disease, non-Hodgkin lymphomas, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia.

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Walter Reed Army Medical Center, 1978 - 1981
  • Medical Resident, Medicine, Walter Reed Army Medical Center, 1975 - 1978
  • M.D., Georgetown University, 1975

Publications

Kasamon, Yvette L., Richard J. Jones, Louis F. Diehl, Hassan Nayer, Michael J. Borowitz, Elizabeth Garrett-Mayer, Richard F. Ambinder, Ross A. Abrams, Zhe Zhang, and Ian W. Flinn. “Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma..” Biol Blood Marrow Transplant 11, no. 1 (January 2005): 39–46. https://doi.org/10.1016/j.bbmt.2004.09.007.

PMID
15625543
Full Text

Huff, Carol Ann, Ephraim J. Fuchs, Stephen J. Noga, Paul V. O’Donnell, Richard F. Ambinder, Louis Diehl, Ivan Borrello, et al. “Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells..” Biol Blood Marrow Transplant 9, no. 5 (May 2003): 312–19.

PMID
12766881
Scholars@Duke

Willard, R. J., G. W. Turiansky, G. P. Genest, B. J. Davis, and L. F. Diehl. “Leukemia cutis in a patient with chronic neutrophilic leukemia..” J Am Acad Dermatol 44, no. 2 Suppl (February 2001): 365–69.

PMID
11174417
Scholars@Duke

Flinn, I. W., J. C. Byrd, C. Morrison, J. Jamison, L. F. Diehl, T. Murphy, S. Piantadosi, et al. “Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies..” Blood 96, no. 1 (July 1, 2000): 71–75.

PMID
10891432
Scholars@Duke

Flinn, I. W., S. N. Goodman, L. Post, J. Jamison, C. B. Miller, S. Gore, L. Diehl, C. Willis, R. F. Ambinder, and J. C. Byr. “A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL..” Ann Oncol 11, no. 6 (June 2000): 691–95. https://doi.org/10.1023/a:1008361914894.

PMID
10942057
Full Text

LeBrun, C. J., L. F. Diehl, K. C. Abbott, P. G. Welch, and C. M. Yuan. “Life expectancy benefits of cancer screening in the end-stage renal disease population..” Am J Kidney Dis 35, no. 2 (February 2000): 237–43.

PMID
10676722
Scholars@Duke

Diehl, L. F., L. H. Karnell, and H. R. Menck. “The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia..” Cancer 86, no. 12 (December 15, 1999): 2684–92.

PMID
10594864
Scholars@Duke

Byrd, J. C., L. H. McGrail, D. R. Hospenthal, R. S. Howard, N. A. Dow, and L. F. Diehl. “Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history study..” Br J Haematol 105, no. 2 (May 1999): 445–47.

PMID
10233419
Scholars@Duke

Shorr, A. F., R. F. Trotta, S. A. Alkins, G. S. Hanzel, and L. F. Diehl. “D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease..” Intensive Care Med 25, no. 2 (February 1999): 207–10.

PMID
10193549
Scholars@Duke

Byrd, J. C., C. Shinn, J. K. Waselenko, E. J. Fuchs, T. A. Lehman, P. L. Nguyen, I. W. Flinn, L. F. Diehl, E. Sausville, and M. R. Grever. “Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53..” Blood 92, no. 10 (November 15, 1998): 3804–16.

PMID
9808574
Scholars@Duke

Pages